Bertrand Filleul

Prospective Randomized Study Comparing Docetaxel, Estramustine, and Prednisone With Docetaxel and Prednisone in Metastatic Hormone-Refractory Prostate Cancer

Jean‐Pascal Machiels, F Mazzeo, Marylène Clausse et al. · Journal of Clinical Oncology · 2008 · 87 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase <scp>II</scp> study of dual phosphoinositol‐3‐kinase ( <scp>PI</scp> 3K) and mammalian target of rapamycin ( <scp>mTOR</scp> ) inhibitor <scp>BEZ</scp> 235 in patients with locally advanced or metastatic transitional cell carcinoma

Emmanuel Seront, Sylvie Rottey, Bertrand Filleul et al. · British Journal of Urology · 2016 · 59 citations · Full text

Medicine, Oncology, Pharmacology +17

A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission.

Bertrand Filleul, A Delannoy, A Ferrant et al. · PubMed · 1994 · 57 citations

Medicine, Hematology, Oncology +5

Infectious complications after 2‐chlorodeoxyadenosine therapy

Eric Van Den Neste, André Delannoy, A. Bosyl et al. · European Journal Of Haematology · 1996 · 46 citations

Medicine, Hematology, Oncology +15

Acute myeloid leukemia: lack of predictive value of sequential quantitative MR imaging during treatment.

B. C. Vande Berg, P. J. Schmitz, J M Scheiff et al. · Radiology · 1995 · 33 citations

Medicine, Hematology, Radiology +17